These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 416892)

  • 21. [Biological criteria of isolated Graves' ophthalmopathy].
    Laferrère B; Madec AM; Orgiazzi J; Mornex R
    Presse Med; 1987 Apr; 16(15):711-4. PubMed ID: 2953009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of the thyroid function by the I-M TRH test (2 mg) (author's transl)].
    Fournier M; Orgiazzi J; Magnon-Pujo B; Quintana J; Mornex R
    Ann Endocrinol (Paris); 1978; 39(1):59-60. PubMed ID: 418731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B; Hoermann R; Roggenbuck U; Hahn S; Mann K; Janssen OE;
    Thyroid; 2005 Sep; 15(9):1047-54. PubMed ID: 16187913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tests of thyroid function important to the ophthalmologist.
    Hurwitz JJ
    Can J Ophthalmol; 1982 Apr; 17(2):49-52. PubMed ID: 6809298
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to thyroid hormones. A disorder frequently confused with Graves' disease.
    Bantle JP; Seeling S; Mariash CN; Ulstrom RA; Oppenheimer JH
    Arch Intern Med; 1982 Oct; 142(10):1867-71. PubMed ID: 6289763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Follow-up studies of patients with negative TRH test and normal thyroid hormone levels].
    Döge H; Hübner O; Kempe K; Riedel A; Ortweiler W
    Z Gesamte Inn Med; 1993 Aug; 48(8):398-400. PubMed ID: 8379222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid storm with encephalopathic symptoms due to Graves' disease and inappropriate secretion of thyrotropin.
    Modignani RL; Venegoni M; Beretta F; Fassina S
    Ann Ital Med Int; 1992; 7(4):250-4. PubMed ID: 1298337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays.
    Spencer CA; Schwarzbein D; Guttler RB; LoPresti JS; Nicoloff JT
    J Clin Endocrinol Metab; 1993 Feb; 76(2):494-8. PubMed ID: 8432796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H; Kasagi K; Morita T; Hidaka A; Kuma K; Konishi J; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orbital lymphoma misdiagnosed as Graves' ophthalmopathy.
    Buescu A; Teixeira P; Coelho S; Donangelo I; Vaisman M
    Endocr Pract; 2001; 7(2):110-2. PubMed ID: 11421556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response to thyrotropin releasing hormone: an objective criterion for the adequacy of thyrotropin suppression therapy.
    Hoffman DP; Surks MI; Oppenheimer JH; Weitzman ED
    J Clin Endocrinol Metab; 1977 May; 44(5):892-901. PubMed ID: 404309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A clinical analysis of Graves' ophthalmopathy and ophthalmic Graves' disease].
    Liao ZQ
    Zhonghua Yan Ke Za Zhi; 1992 Jul; 28(4):236-9. PubMed ID: 1299571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of a simple oral short test with the TSH releasing hormone (TRH) and its use in thyroid diagnosis].
    Staub JJ; Girard J; Gemsenjäger E
    Schweiz Med Wochenschr; 1976 Dec; 106(50):1839-42. PubMed ID: 827812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orbital lymphoma mimicking ophthalmopathy in a patient with Graves'.
    Moura Neto A; Denardi FC; Delamain MT; Tambascia MA; Vassallo J; Caldato R; Zantut-Wittmann DE
    Am J Med Sci; 2012 Nov; 344(5):418-21. PubMed ID: 22885624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs.
    Notsu K; Oka N; Masaki Y; Furuya H; Kato Y
    J Clin Endocrinol Metab; 1991 Aug; 73(2):396-400. PubMed ID: 1713218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the occurrence of ophthalmopathy in Graves' disease.
    Marcocci C; Bartalena L; Bogazzi F; Panicucci M; Pinchera A
    Acta Endocrinol (Copenh); 1989 Apr; 120(4):473-8. PubMed ID: 2718699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.